Baxter International | BAX - Le Bénéfice D'Exploitation

Prix De L'Action
18.16
Variation Quotidienne
-0.25 -1.36%
Mensuellement
6.07%
Annuel
-39.91%
Q2 Prévisions
17.77




Le Bénéfice D'Exploitation Changement Date
Abbott USD 1.85B 399M 2026-03
AngioDynamics USD -2.51M 5.41M 2025-09
Artivion USD 4.79M 6.85M 2025-12
AtriCure USD 2.49M 2.28M 2025-12
Avanos Medical USD 24.77M 5.8M 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Boston Scientific USD 1.24B 203M 2025-12
Cooper Companies USD 212.8M 72.4M 2025-12
Dexcom USD 323M 80.5M 2025-12
Edwards Lifesciences USD 514.7M 144.4M 2026-03
Fresenius EUR 713M 139M 2025-12
Globus Medical USD 181.31M 298.83M 2025-12
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
ICU Medical USD 26.09M 770K 2025-12
Inogen USD -7.79M 728K 2024-09
Insulet USD 146.3M 28.6M 2025-12
Integra LifeSciences USD 66M 54.24M 2025-12
Intuitive Surgical USD 859.7M 5.6M 2026-03
J&J USD 6.62B 1.03B 2026-03
Laboratory Of America USD 382M 15.3M 2025-12
Masimo USD 83.9M 300K 2025-12
Medtronic USD 1.74B 40M 2025-12
Merit Medical Systems USD 54.2M 11.58M 2025-12
Quest Diagnostics USD 399M 13M 2026-03
Smith & Nephew USD 440M 50M 2025-12
Stryker USD 1.97B 609M 2025-12
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 36.34M 445.24M 2025-12
Terumo JPY 43.88B 1.21B 2025-12
Zimmer Biomet Holdings USD 302.9M 35.4M 2025-12